Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-12-10

Clinical Trial Update: Safety and Acceptability of Using a Rewetting Drop With Contact Lens Wear [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating the safety and acceptability of using a rewetting eye drop with contact lens wear; results were posted 2009-12-10.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rewetting eye drop for contact lens wear

Snippet

Sponsor: Allergan | Conditions: Ametropia | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2009-12-10